Search results
Sartorius AG is an international pharmaceutical and laboratory equipment supplier, covering the segments of Bioprocess Solutions and Lab Products & Services. In September 2021, Sartorius has been admitted to the DAX, Germany's largest (Blue chip) stock market index. [2] As a leading partner to the biopharmaceutical research and industry ...
2 days ago · Headquartered in Chicago, Illinois, Hub International Limited is a leading full-service global insurance broker and financial services firm providing risk management, insurance, employee benefits, retirement and wealth management products and services. With more than 18,000 employees in offices located throughout North America, Hub’s vast network of specialists brings clarity to a changing ...
A Trusted Partner of Life Science Research and the Biopharmaceutical Industry. Many diseases, such as cancer, dementia or inflammatory diseases, are still incurable. Sartorius is helping biotech scientists and engineers across the entire globe to develop and manufacture medications from the first idea to production.
- Otto-Brenner-Str. 20, Goettingen, 37079, GÖ
- A Quick Recap on Bio-Rad and The Industry
- The Sartorius Secret
- The valuation Equation
- Due Diligence Pays Off
Bio-Rad Laboratories manufactures products for the clinical diagnostics and life sciences industries. The life sciences label is actually an umbrella term that covers the fields of biotechnology, pharmaceuticals, medical technology, and biomedicine. In terms of operations, Bio-Rad's clinical diagnostics business, which sells laboratory devices and ...
Bio-Rad's equity investment in German pharmaceuticals and lab equipment provider Sartorius AGis a unique value proposition for shareholders that also separates the company from its peers. It began investing in Sartorius back in 2003 with an initial capital outlay of $10.4 million. By the end of 2004, Bio-Rad held an approximate 23% stake in its Ger...
Knowing all this, let's reexamine Bio-Rad from a valuation perspective. The company's enterprise value (EV) is about 30 times its trailing-12-month (TTM) EBITDA, which is an approximate 60% premium to its peer group. But the EV calculation contains the Sartorius holding as an equity holding, whereas EBITDA does not. To make an apples-to-apples comp...
Foolish investors know that true investment success comes from prudent due diligence and a long-term mindset. Bio-Rad is a prime example of how these elements can combine to skew the risk/reward calculus in the diligent investor's favor. Knowing what we do now about Sartorius's true value and the historical relationship between the stocks' performa...
Sartorius preference share ended 2023 at a price of 333 euros, which corresponds to a decline of about 10 percent year over year. The Sartorius ordinary share closed 21 percent lower at 265 euros. To put this into perspective: Despite the decline, the market capitalization of Sartorius has increased more than 13-fold over the past ten years.
Description. Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales ...
People also ask
Who is Sartorius AG?
Who manages Sartorius AG?
Where is Sartorius headquartered?
Is Sartorius a good company?
Does Sartorius have insurance?
What was Sartorius AG's net profit?
Sartorius is a globally operating company with subsidiaries in more than 30 countries. The holding company Sartorius AG is the parent corporation of the Sartorius Group. The corporation is headquartered in Göttingen, Germany, and is listed on the German Stock Exchange. Sartorius manages its bioprocess business as a legally independent subgroup ...
